The findings indicate that the O-GlcNAcylation of the two tumor suppressors FoxO1 and p53 enhances their activity; this is rather counterintuitive to the fact that cancer increases the level of protein O-GlcNAcylation. The gene discussed is FOXO1; the disease is neoplasm.